PEP-1

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePEP-1
Drug Alias NamePEP1
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTranscription factor SOX-9 inhibitors
TargetsTranscription factor SOX-9
Therapy Area/IndicationsSpinal InjuriesBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSinobioway Biomedicine Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinobioway Biomedicine Co Ltd
Inactive CompaniesN/A
Active IndicationsSpinal InjuriesBrain Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A